Chief of Gastroenterology/Hepatology-StThomas Hospital. Assistant Clinical Professor of Medicine -Vanderbilt School of Medicine
Gastroenterology
Dr. Ronald E. Pruitt, MD
|
|
Give Review
Ronald Pruitt is an expert in the field of Gastroenterology. He studied medicine at University of Alabama Medical Center. University of Alabama Medical Center is ranked 37/17 in Research/PrimaryCare. He has 7 awards "Fellow (FACG)", "Fellow (FACP)", "Meaningful Use Stage 1 and 2 Certification", "Fellow (AGAF)", "Top MD", "Americas Top Gastroenterologists" and "Publication of Medicine's Best". Doctor Ronald E. Pruitt, MD is a published physician as well. He has 21 publications published. The latest was: Budesonide enema for the treatment of active, distal ulcerative colitis and proctitis: a dose-ranging study. U.S. Budesonide enema study group. He accepts Medicare.
Publications
- Once-daily mesalamine granules for maintaining remission of ulcerative Colitis: pooled analysis of efficacy, safety, and prognostic factors.
- Computer-assisted personalized sedation for upper endoscopy and Colonoscopy: a comparative, multicenter randomized study.
- Clinical trial: once-daily mesalamine granules for maintenance of remission of ulcerative Colitis - a 6-month placebo-controlled trial.
- Radiofrequency ablation of Barrett''s Esophagus: outcomes of 429 patients from a multicenter community practice registry.
- Safety and efficacy of a new 3.3 g b.i.d. tablet formulation in patients with mild-to-moderately-active ulcerative Colitis: a multicenter, randomized, double-blind, pl...
- Five-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib Trial.
- The Plicator procedure for the treatment of gastroesophageal reflux Disease: a registry study.
- Circumferential ablation of Barrett''s Esophagus that contains high-grade dysplasia: a U.S. Multicenter Registry.
- Endoscopic full-thickness plication for the treatment of gastroesophageal reflux Disease: A randomized, sham-controlled trial.
- Celecoxib for the prevention of sporadic Colorectal adenomas.
- A phase 1/2A trial of STA 5326, an oral interleukin-12/23 inhibitor, in patients with active moderate to severe Crohn's Disease.
- Open-label, dose-ranging pilot study of 4 weeks of low-dose therapy with sodium phosphate tablets in chronically constipated adults.
- Treatment of ulcerative Colitis with balsalazide: response to editorial by Drs. Farrell and Peppercorn and letter to the editor by Dr. Hanauer.
- Balsalazide is superior to mesalamine in the time to improvement of signs and symptoms of acute mild-to-moderate ulcerative Colitis.
- A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate...
- Budesonide enema for the treatment of active, distal ulcerative Colitis and proctitis: a dose-ranging study. U.S. Budesonide enema study group.
- Oral mesalamine (Asacol) for mildly to moderately active ulcerative Colitis. A multicenter study.
- Oral asacol in the treatment of mild to moderate ulcerative Colitis: the Nashville experience.
- Diabetic gastroparesis in a patient with Parkinson's Disease: effective treatment with domperidone.
- Muscarinic cholinergic receptor subtype on frog Esophageal peptic cells: binding and secretion studies.
Schools
University Of North Carolina Chapel Hill School Of Medicine
University Of Alabama School Of Medicine
University of North Carolina At Chapel Hill
Procedures Preformed
- Biliary Drainage
- Colon Cancer Screening
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Endoscopic Common Duct Stone Removal
- View All
Conditions Treated
- Abdominal Pain
- Anemia
- Barrett's Esophagus
- Benign Neoplasm of the Digestive System
- View All
Doctors Specialties
- Gastroenterology
- Internal Medicine
Accepted Insurances
Awards
- Fellow (FACG)
- Fellow (FACP)
- Meaningful Use Stage 1 and 2 Certification
- Fellow (AGAF)
- Top MD
- Americas Top Gastroenterologists
- Publication of Medicine's Best
Education
-
University of Alabama Medical Center -
University of North Carolina at Chapel Hill School of Medicine
Hospital
-
Vanderbilt Hospital and Clinics
Drug Facts
| NPI NUMBER | 1770582140 | |
| NPPES Provider LastName | PRUITT | |
| NPPES Provider FirstName | RONALD | |
| NPPES Provider ZIPCode | 372052013 | |
| NPPES Provider State | TN | |
| Specialty Description | Gastroenterology | |
| Total Claim Count | 1311.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 16.0 | |
| Percent Opioid Claims | 1.22 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1770582140 |
| Last Name Of The Provider | PRUITT |
| First Name Of The Provider | RONALD |
| View All |
Similar Doctors
|
Dr. Christopher R. Janowiecki, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Judit Marton, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew E. Scanga, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Robert W. Herring Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph P. Parker, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Saeed Fakhruddin, MD |
|
Dr. George D. Wright, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Ira E. Stein, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jonathan Benson, MD |
|
|
Dr. Christopher M. White, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Buntwal N. Somayaji, MB
This Doctor is OpenDoctor Recommended.
|